Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

European Hospital Leverages OmniComm Systems’ Tr

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
Posted On: 12/07/2016 8:15:29 AM
Avatar
Posted By: News Desk 2018
European Hospital Leverages OmniComm Systems’ TrialMaster® EDC To Integrate Electronic Health Records

FORT LAUDERDALE, Fla., Dec. 07, 2016 (GLOBE NEWSWIRE) -- A large nationwide infectious disease observational study in Europe will receive electronic data capture (EDC) technology and related services from OmniComm Systems, Inc. (OTCQX:OMCM), a leading provider of clinical data management technology.  As an integral part of the innovative study, a European research hospital selected OmniComm’s TrialMaster EDC to integrate privacy-protected patient data from the hospital’s electronic health records, a process known as eSource.

The study is unique because 100 percent of the research data will be pulled from electronic health records, as opposed to traditional paper sources.  Once the data is imported into TrialMaster, the study will be conducted using OmniComm’s EDC technology.  TrialMaster will be used as a data management engine - to aggregate, monitor, review, analyze, report and submit study data to regulators.

“This infectious disease study is innovative, and TrialMaster’s role in the project is unique for several reasons. The role of EDC becomes more focused on backend data management and review, as opposed to frontend data capture,” said Ken Light, executive vice president, professional services at OmniComm Systems.  “We are extremely proud that the European research hospital is leveraging TrialMaster for the study of a major infectious disease. We are pleased to be partnering and working with such a world-class organization.”

Electronic source data guidance issued by the Food and Drug Administration in 2013 and the European Medicines Agency in 2010 opened the door and set new standards for how data can be gathered for clinical trials and studies.  Those guidelines now allow researchers to pull data directly from e-records and mobile devices, while also providing strict safeguards for protecting patient privacy.  For example, to maintain patient privacy, the European hospital will remove patient identities prior to exporting the electronic data into TrialMaster.

There are several benefits of this method of data capture, including improved quality of data, greater efficiency and enhanced timeliness.  OmniComm was selected for the project because of these factors:

  • Ease of integration . OmniComm’s interoperable technology integrates well with other systems.
  • Experience and expertise . OmniComm’s staff provides extensive background and expertise about industry trends, regulations and best practices for eSourcing.

In fact, OmniComm’s expertise in integrating electronic medical record (EMR) systems was a key factor in the selection decision.  Data captured from the research hospital’s EMR will automatically import into TrialMaster. This comprehensive eSource solution will help the institution realize the following:

  • Accelerate the process of data capture.
  • Eliminate unnecessary duplication of data.
  • Reduce transcription errors.
  • Ensure the accuracy and completeness of data.

Supporting   Information

  • TrialMaster
  • OmniComm Systems Signs Five-Year, $8.4 Million Contract With Top-Tier Research Hospital
  • Five-Year Agreement with Top 5 US Medical Research University

About OmniComm Systems, Inc. OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,800 clinical trials. For more information, visit www.omnicomm.com .

Trademarks OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.

Contact Info Dennis Constantinou OmniComm Systems, Inc. +1.954.473.1254 dconstantinou@omnicomm.com



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us